Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1999-10-13
2000-08-15
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3800
Patent
active
061036951
ABSTRACT:
The present invention provides a method of producing a pleurodesis in a mammal, comprising introducing a therapeutically effective dose of a pharmaceutical composition comprising TGF.beta. into the pleural cavity.
REFERENCES:
patent: 5312331 (1994-05-01), Knoepfler
patent: 5478837 (1995-12-01), Rodgers et al.
patent: 5597578 (1997-01-01), Brown et al.
Light et al., "Pleural sclerosis for the treatment of pneumothorax and pleural effusion", Lung 1997; 175:213-223.
Light et al., "Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothrax", JAMA 1990; 264:2224-2230.
Vargas et al., "Effectiveness of bleomycin in comparison to tetracycline as pleural sclerosing agent in rabbits", Chest 1993; 104:1582-1584.
Xie et al., "Serial observations after high dose talc slurry in the rabbit model for pleurodesis", Lung 1998; 176:299-307.
Wu et al., "Doxycycline Pleurodesis in rabbits. Comparison of results with and without chest tube." Chest 1998; 114:563-568.
Sahn et al., "The effect of common sclerosing agents on the rabbits pleural space", Am Rev Respir Dis 1981; 124:65-67.
Vargas et al., "Acute and chronic pleural changes after the intrapleural instillation of mitoxantrone in rabbits", Lung 1998; 176:227-236.
Kennedy et al., "Talc slurry pleurodesis, Pleural fluid and histologic analysis", Chest 1995; 107:1707-1712.
Light et al., "Comparison of the effectiveness of tetracycline and minocycline as pleural sclerosing agents-In rabbits", Chest 1994; 106:577-582.
Sassoon et al., "Temporal evolution of pleural fibrosis induced by intrapleral minocycline injection", Am J. Respir Crit Care Med 1995; 151:791-794.
Xie et al., "Systemic corticosteroids decrease the effectiveness of talc pleurodesis", Am J. Respir Crit Care Med 1998; 157:1441-1444.
Cheng et al., "The effects of intrapleural polyclonal anti-tumor necrosis factor alpha (TNF.alpha.) Fab fragments on pleurodesis in rabbits", Lung 2000; 178:000-000.
Teixeira, et al., "The effect of corticosteroids on pleurodesis induced with doxycycline in rabbits", Chest 1997; 112:137S.
Walker-Renard, et al., "Chemical pleurodesis for malignant pleural effusions", Ann Intern Med 1994; 120:56-64.
Milanez-Campos et al., "Respiratory failure due to insufflated talc", Lancet 1997; 349:251-252.
Davidson Jeffrey M.
Lane Kirk B.
Light Richard
Henley III Raymond
Vanderbilt University
LandOfFree
Method of producing pleurodesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of producing pleurodesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing pleurodesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2006905